Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
Pfizer to Buy Anacor for $4.5 Billion
Pfizer Inc.
Bayer stops riociguat study on safety concerns
Bayer has terminated with immediate effect a mid-stage trial assessing riociguat in pulmonary hypertension associated with idiopathic interstitial pneumonia because of serious safety concerns.
Larry Ellison Gives $200 Million to USC for Cancer Research
Larry Ellison, co-founder of database giant Oracle Corp.
Top health official misled Congress on Obamacare exchange spending, House panel says
A House panel said Tuesday that a top administration health official misled Congress last year by seeming to suggest that the government had already recaptured hundreds of millions of dollars from str...
NICE deems Bristol-Myers' Opdivo too pricey for lung cancer
England’s cost-effectiveness watchdogs are influential arbiters in the drug-reimbursement world.
Baxter close on deal for India's Gland Pharma: Sources
Baxter CEO José Almeida told analysts last month the company was looking for manageable M&A deals and that sterile injectables was an area he is focused on.
Mylan launches generic version of Apresoline injection in US
Mylan announced the US launch of Hydralazine Hydrochloride Injection USP, 20 mg/mL, which is a generic version of Novartis' Apresoline Injection, 20 mg/mL.
Allergan Receives FDA Approval to Launch First Generic Version of Crestor
Allergan, a leading global pharmaceutical company, confirmed that it has received final approval from the U.
Mylan taps Sarah Jessica Parker to rep anaphylaxis film contest
May is Food Allergy Action Month, and Mylan is making the most of it.
NICE gives tentative broad approval to both Repatha, Praluent
Sanofi and Regeneron put a list price of about $5,780 on their new-gen cholesterol lowering drug Praluent when they took it to the U.
Soon, a botanical drug to cure dengue!
New Delhi.
High stress triggers Alzheimer risk: Study
New Delhi.
35
36
37
38
39
40
41
42
43
